Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Study of LEE011 With Everolimus in Patients With Advanced Neuroendocrine Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03070301
Recruitment Status : Recruiting
First Posted : March 3, 2017
Last Update Posted : May 22, 2019
Sponsor:
Collaborators:
Novartis
Dana-Farber Cancer Institute
M.D. Anderson Cancer Center
Information provided by (Responsible Party):
Memorial Sloan Kettering Cancer Center

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : February 2020
  Estimated Study Completion Date : February 2020